scholarly journals Pharmacologic increase in HIF1α enhances hematopoietic stem and progenitor homing and engraftment

Blood ◽  
2014 ◽  
Vol 123 (2) ◽  
pp. 203-207 ◽  
Author(s):  
Jennifer M. Speth ◽  
Jonathan Hoggatt ◽  
Pratibha Singh ◽  
Louis M. Pelus

Key Points dmPGE2 stabilizes the transcription factor HIF1α in stem and progenitor cells. Pharmacologic stabilization of HIF1α increases CXCR4 and enhances stem and progenitor homing and engraftment.

Blood ◽  
2017 ◽  
Vol 130 (25) ◽  
pp. 2762-2773 ◽  
Author(s):  
Xin Zhao ◽  
Shouguo Gao ◽  
Zhijie Wu ◽  
Sachiko Kajigaya ◽  
Xingmin Feng ◽  
...  

Key Points We distinguished aneuploid cells from diploid cells within the hematopoietic stem and progenitor cells using scRNA-seq. Monosomy 7 cells showed downregulated pathways involved in immune response and maintenance of DNA stability.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 1284-1284
Author(s):  
Zhongfa Yang ◽  
Karen Drumea ◽  
James Cormier ◽  
Junling Wang ◽  
Xuejun Zhu ◽  
...  

Abstract Abstract 1284 GABP is an ets transcription factor that regulates genes which are required for normal hematopoietic development. In myeloid cells, GABP is an essential component of a retinoic acid-inducible enhanceosome that mediates granulocytic gene expression and, in lymphoid cells, GABP regulates expression of IL7-R and the essential transcription factor, Pax5. GABP is a tetrameric complex that includes GABPa, which binds DNA via its ets domain, and GABPb, which contains the transcription activation domain. Genetic disruption of mouse Gabpa caused early embryonic lethality. We created mice in which loxP recombination sites flank exons that encode the Gabpa ets domain, and bred them to mice that bear the Mx1Cre recombinase; injection with pIC induced Cre expression and efficiently deleted Gabpa in hematopoietic cells. One half of the Gabpa knock-out (KO) mice died within two weeks of pIC injection in association with widespread visceral hemorrhage. Gabpa KO mice exhibited a rapid loss of mature granulocytes, and residual myeloid cells exhibited myelodysplasia due, in part, to regulation by Gabp of the transcriptional repressor, Gfi-1. We used bone marrow transplantation to demonstrate that the defect in Gabpa null myeloid cells is cell intrinsic. Although hematopoietic progenitor cells in Gabpa KO bone marrow were decreased more than 100-fold compared to pIC treated control mice, there was not a statistically significant difference in the numbers of Lin−c-kit+Sca-1− hematopoietic stem cells (HSCs) between KO and control mice. Genetic disruption of Gfi-1 disruption in HSCs caused increased cell cycle activity – an effect that is diametrically opposite of the effect of Gabpa KO; this suggests that the effect of Gabpa on HSCs is not due to its control of Gfi-1. In contrast, Gabpa KO HSCs exhibited a marked decrease in cell cycle activity, but did not demonstrate increased apoptosis. The defects in S phase entry of Gabpa null HSCs are reminiscent of the cell cycle defects in Gabpa null fibroblasts, in which expression of Skp2 E3 ubiquitin ligase, which controls degradation of the cyclin dependent kinase inhibitors (CDKIs) p21 and p27, was markedly reduced following Gabpa disruption. We showed that Gabpa KO cells express reduced levels of Skp2. We propose that GABP controls self-renewal and proliferation of mouse bone marrow stem and progenitor cells, in part, through its regulation of Skp2. Thus, Gabpa is a key regulator of myeloid differentiation through its control of Gfi-1, but it is required for cell cycle activity of HSCs, by a distinct effect that may be due to its control of Skp2 and CDKIs. Disclosures: No relevant conflicts of interest to declare.


Blood ◽  
2017 ◽  
Vol 129 (18) ◽  
pp. 2479-2492 ◽  
Author(s):  
Wei Shi ◽  
Therese Vu ◽  
Didier Boucher ◽  
Anna Biernacka ◽  
Jules Nde ◽  
...  

Key Points Combined loss of Ssb1/Ssb2 induces rapid lethality due to replication stress–associated loss of hematopoietic stem and progenitor cells. Functionally, loss of Ssb1/Ssb2 activates p53 and IFN pathways, causing enforced cell cycling in quiescent HSPCs and apoptotic cell loss.


Blood ◽  
2015 ◽  
Vol 125 (12) ◽  
pp. 1890-1900 ◽  
Author(s):  
Sarah A. Kinkel ◽  
Roman Galeev ◽  
Christoffer Flensburg ◽  
Andrew Keniry ◽  
Kelsey Breslin ◽  
...  

Key Points Depletion of Jarid2 in mouse and human hematopoietic stem cells enhances their activity. Jarid2 acts as part of PRC2 in hematopoietic stem and progenitor cells.


2008 ◽  
Vol 33 (2) ◽  
pp. 159-169 ◽  
Author(s):  
Peter G. Fuhrken ◽  
Chi Chen ◽  
Pani A. Apostolidis ◽  
Min Wang ◽  
William M. Miller ◽  
...  

Differentiation of hematopoietic stem and progenitor cells is an intricate process controlled in large part at the level of transcription. While some key megakaryocytic transcription factors have been identified, the complete network of megakaryocytic transcriptional control is poorly understood. Using global gene expression microarray analysis, Gene Ontology-based functional annotations, and a novel interlineage comparison with parallel, isogenic granulocytic cultures as a negative control, we closely examined the mRNA level of transcriptional regulators in megakaryocytes derived from human mobilized peripheral blood CD34+hematopoietic cells. This approach identified 199 differentially expressed transcription factors or transcriptional regulators. We identified and detailed the transcriptional kinetics of most known megakaryocytic transcription factors including GATA1, FLI1, and MAFG. Furthermore, many genes with transcription factor activity or transcription factor binding activity were identified in megakaryocytes that had not previously been associated with that lineage, including BTEB1, NR4A2, FOXO1A, MEF2C, HDAC5, VDR, and several genes associated with the tumor suppressor p53 (HIPK2, FHL2, and TADA3L). Protein expression and nuclear localization were confirmed in megakaryocytic cells for four of the novel candidate megakaryocytic transcription factors: FHL2, MXD1, E2F3, and RFX5. In light of the hypothesis that transcription factors expressed in a particular differentiation program are important contributors to such a program, these data substantially expand our understanding of transcriptional regulation in megakaryocytic differentiation of stem and progenitor cells.


Blood ◽  
2017 ◽  
Vol 129 (21) ◽  
pp. 2939-2949 ◽  
Author(s):  
Darja Karpova ◽  
Julie K. Ritchey ◽  
Matthew S. Holt ◽  
Grazia Abou-Ezzi ◽  
Darlene Monlish ◽  
...  

Key Points Prolonged inhibition of CXCR4/CXCL12 signaling results in exceptional mobilization along with an expansion of the BM HSPC pool. Reversible inhibition of the CXCR4/CXCL12 axis may represent a novel strategy to restore damaged BM.


Blood ◽  
2016 ◽  
Vol 127 (26) ◽  
pp. 3398-3409 ◽  
Author(s):  
Xiaoli Wang ◽  
David Haylock ◽  
Cing Siang Hu ◽  
Wioleta Kowalczyk ◽  
Tianbo Jiang ◽  
...  

Key Points Treatment of MF CD34+ cells with a TPO receptor antagonist selectively depletes MF HSCs and HPCs. Agents that target the TPO receptor represent potentially new approaches for the treatment of MF patients.


Blood ◽  
2017 ◽  
Vol 129 (23) ◽  
pp. 3074-3086 ◽  
Author(s):  
Jared A. Wallace ◽  
Dominique A. Kagele ◽  
Anna M. Eiring ◽  
Carissa N. Kim ◽  
Ruozhen Hu ◽  
...  

Key Points miR-155 promotes myeloproliferation in the bone marrow, spleen, and blood of mice carrying the FLT3-ITD mutation. miR-155 suppresses the IFN response in FLT3-ITD+ mouse hematopoietic stem and progenitor cells, as well as FLT3-ITD+ human AML cells.


Sign in / Sign up

Export Citation Format

Share Document